Miltenyi Biotec is a global biotechnology company committed to empowering scientific discovery and advancing cellular therapy. With a comprehensive portfolio of instruments, reagents, and services, they support researchers and clinicians worldwide in areas such as immunology, oncology, neuroscience, and regenerative medicine. Their innovative tools facilitate sample preparation, cell separation and analysis, molecular biology, and clinical applications, driving progress from basic research through to translational science and commercial-scale cell and gene therapy manufacturing.
Serves as the central hub for global operations, including research and development leadership, core manufacturing, corporate strategy, and administration.
The Bergisch Gladbach campus features state-of-the-art research laboratories, dedicated GMP (Good Manufacturing Practice) facilities for cell therapy product development and manufacturing, advanced training centers for customers and employees, and modern office spaces designed to foster collaboration.
The work culture at Miltenyi Biotec's headquarters is characterized by a strong emphasis on scientific innovation, collaboration across multidisciplinary teams, and a shared mission to improve patient lives. Employees often describe it as dynamic, research-intensive, and fostering continuous learning and development in the cutting-edge field of biotechnology.
As the global headquarters, Bergisch Gladbach is the nerve center for Miltenyi Biotec's worldwide operations, R&D strategy, and product innovation. It plays a crucial role in developing and manufacturing key technologies that are distributed globally.
Miltenyi Biotec supports a wide range of functions globally, including extensive research and development, multi-site manufacturing (including GMP-grade products for clinical use), international sales and marketing operations, localized technical and application support, customer service, and dedicated support for clinical trials. Their presence spans across numerous countries, enabling them to serve the biomedical research and cellular therapy communities worldwide in fields like immunology, oncology, neuroscience, and regenerative medicine.
Friedrich-Ebert-Straße 68
Bergisch Gladbach
North Rhine-Westphalia
Germany
Address: 2303 Lindbergh Street, Auburn, CA 95602, USA
Primary operational base for North and South American markets, ensuring regional customer support, product availability, and market-specific application development.
Address: 1201 Clopper Road, Gaithersburg, MD 20878, USA
Acts as a strategic center for clinical and biopharmaceutical collaborations, particularly supporting clients involved in cell and gene therapy development in the biotech-rich Mid-Atlantic region.
Address: Building 2, Lane 2388, Xiupu Road, Pudong New Area, 201315 Shanghai, China
Supports the growing demand for advanced biomedical research tools and cellular therapy solutions in China, fostering local collaborations and market penetration.
Address: Shinjuku Center Bldg. 48F, 1-25-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo 163-0648, Japan
Caters to the advanced needs of the Japanese biomedical research community and healthcare sector, ensuring access to innovative technologies and expert support.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Miltenyi Biotec' leadership includes:
Miltenyi Biotec has been backed by several prominent investors over the years, including:
The most significant executive change in the last 12 months was the appointment of Dr. Boris Stoffel as the new Chief Executive Officer in July 2023. He succeeded founder Stefan Miltenyi, who transitioned to the role of President to focus on strategic innovation. As a private company, Miltenyi Biotec has limited public disclosures on other specific C-level team changes.
Discover the tools Miltenyi Biotec uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Miltenyi Biotec primarily utilizes the email format `[first].[last]@miltenyibiotec.com`. This is the most common structure for professional communication within the organization, facilitating direct contact with employees. While other formats might exist in isolated cases, this pattern is predominant.
[first].[last]@miltenyibiotec.com
Format
jane.doe@miltenyibiotec.com
Example
80%
Success rate
Miltenyi Biotec Press Release • May 23, 2024
Miltenyi Biotec announced the launch of PrimeSurface VXP® Cell Culture Vessels, specifically designed for the efficient, scalable, xeno-free, and feeder-free expansion of human pluripotent stem cells (hPSCs). This development aims to support advancements in regenerative medicine research and clinical applications by providing improved cell culture solutions....more
PR Newswire (via Miltenyi Biotec) • October 25, 2023
Miltenyi Biotec and Bioqube Ventures' BMO (Biotech Manufacturing Organization) announced a strategic partnership to advance automated cell and gene therapy (CGT) manufacturing. The collaboration aims to make these innovative therapies more accessible and affordable by leveraging Miltenyi's CliniMACS Prodigy® platform and BMO's manufacturing expertise....more
Miltenyi Biotec Press Release • July 3, 2023
Effective July 1, 2023, Dr. Boris Stoffel assumed the role of Chief Executive Officer at Miltenyi Biotec. Founder Stefan Miltenyi transitioned to the role of President, where he will continue to focus on innovation and the company's long-term strategic direction....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Miltenyi Biotec, are just a search away.